Stock Events

Stock Events

Atea Pharmaceuticals (AVIR) Q2 2025 Earnings

12MayConfirmed

Q3 2024

Q4 2024

Q1 2025

Q2 2025

-0.66

-0.54

-0.41

-0.29

Details

Expected EPS

-0.503333

Actual EPS

-0.4

Surprise EPS

0.1

Surprise Percent

+20.53%

Description

Atea Pharmaceuticals (AVIR) has reported earnings of -0.4 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.